Search

everythinglearnresearchcommunity

for

Search:↓

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Dutasteride effectively treats enlarged prostate, reduces prostate cancer risk, and promotes hair regrowth with few side effects.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Parkinson's disease is linked to skin disorders and skin cells help in studying the disease.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Skin aging is caused by stem cell damage and can potentially be delayed with treatments like antioxidants and stem cell therapy.

Laser and light treatments can effectively remove hair long-term.

Researchers found potential urine markers for polycystic ovary syndrome, including testosterone-glucuronide and 11α-hydroxyprogesterone, which may help diagnose the condition.

Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Eating less starch and dairy helped overweight women with PCOS lose weight and improve symptoms.

COVID-19 may harm male fertility and damage the reproductive system.

About 5% of Thai university girls aged 17-19 have polycystic ovary syndrome, with moderate acne being a strong risk factor.

A rare benign skin tumor showed unusual features of sebaceous and sweat glands, important for correct diagnosis.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Exemestane is effective and safe for treating certain breast cancers, with mild side effects, but needs more research on long-term effects.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

New acne treatments include combination creams, advanced retinoids, and light therapies, focusing on safety and patient adherence.

Healthcare providers should start with simple fertility tests and treatments before referring patients to specialists.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.